New York, NY -- (SBWIRE) -- 09/27/2013 -- StockMarketIntel.com issues a special report on the following stocks: Liberator Medical Holdings, Inc. (OTCBB:LBMH), Axa SA (ADR) (OTCMKTS:AXAHY), diaDexus, Inc. (OTCMKTS:DDXS), LONZA GROUP AG (OTCMKTS:LZAGY)
Liberator Medical Holdings, Inc. (OTCBB:LBMH) recently declined -3.46%, while trading on 33,796 shares, at the price of $2.23. The stock changed hands in a range of $2.22 to $2.31 up till now, bringing its market capitalization at about $118.72 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.56 and was moved to the maximum level of $2.42. Liberator Medical Holdings, Inc. is a national direct-to-consumer provider of medical supplies to Medicare-eligible seniors. The Company’s wholly owned subsidiary, Liberator Medical Supply, Inc. (LMS), is a direct-to-consumer, provider of Medicare Part B Benefits. LMS has four main product lines: diabetes, urological, ostomy and mastectomy.
Has LBMH Found The Bottom and Ready To Move Up? Find Out Here
Axa SA (ADR) (OTCMKTS:AXAHY) added 0.64% recently, in the current trading session, at $23.56 with a total volume of 12,850 shares. The stock, on average, trades on a volume of 100,680 shares. It floated in a range of $23.39 to $23.56during the recent trading session, with a beta value of 2.37. Its market capitalization now moved to about $55.97 billion. In the past 52 weeks, the share price has not declined below $14.50 or above $25.00. Axa SA, (AXA), is a France-based holding company engaged in the business of financial protection, insurance and asset management. The Company operates in three segments: Life & Savings, Property & Casualty Insurance and Asset Management.
Will AXAHY Continue To Move Higher? Find Out Here
diaDexus, Inc. (OTCMKTS:DDXS) recently declined -4.74% and was moving within a range of $1.75-$1.91, its current trading price is $1.81. The stock is moving up till now with a total volume of 134,999 shares, versus an average volume of 225,050 shares. The share price hit its 52-week low of $0.28 and $1.95 was the best price. diaDexus, Inc. (diaDexus) is a medical diagnostics company. The Company is focused on the development and commercialization of in vitro diagnostic products addressing unmet needs in cardiovascular disease. diaDexus’s product, the PLAC Test, helps identify individuals suffering a heart attack or stroke, the #1 and #3 causes of death, respectively in the United States.
Why Should Investors Buy DDXS After the Recent Fall? Just Go Here and Find Out
LONZA GROUP AG (OTCMKTS:LZAGY) added 0.86% in its current trading activity, bringing its market capitalization around $4.30 billion. The share price, after opening at $8.17, hit a high of $8.20 and hovered above $8.17, while its recent trading price was $8.20. The total number of shares changed hands during the current session up till now was 7,297 shares, as compared to average trading volume of 116,135 shares. Lonza Group AG supplies products and services to the pharmaceutical and biotechnology, healthcare, and life-science industries worldwide. Its Custom Manufacturing segment manufactures active ingredients that are used in critical drugs for treating patients with cardiovascular diseases, cancer, neurological, and infectious diseases.
For How Long LZAGY will fight for Profitability? Read This Trend Analysis report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)